Back
Keros Therapeutics Stock Price Chart

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
KROS
Keros Therapeutics
Last Price:
$11.61
Seasonality Move:
-23.1%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.62 | Sell |
20-day SMA: | 11.09 | Buy |
50-day SMA: | 12 | Sell |
200-day SMA: | 41.12 | Sell |
8-day EMA: | 11.51 | Buy |
20-day EMA: | 11.5 | Buy |
50-day EMA: | 16.19 | Sell |
200-day EMA: | 35.52 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.5 | Sell |
Relative Strength Index (14 RSI): | 46.18 | Sell |
Chaikin Money Flow: | -183366 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Keros Therapeutics Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 11.58 while KROS 8-day simple moving average is 11.62, which is a Sell signal.
-
The stock price of KROS is 11.58 while Keros Therapeutics 20-day SMA is 11.09, which makes it a Buy.
-
Keros Therapeutics 50-day simple moving average is 12.00 while KROS share price is 11.58, making it a Sell technically.
-
KROS stock price is 11.58 and Keros Therapeutics 200-day simple moving average is 41.12, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
22
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $11.58. The Score for KROS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
469.7M
Price in USD:
11.58
Share Volume:
374.1K
Keros Therapeutics 52-Week Range
52-Week High:
72.37
52-Week Low:
9.78
Sell
22
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?The Keros Therapeutics stock price is 11.58 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 11.58 while KROS 8-day exponential moving average is 11.51, which is a Buy signal.
-
The stock price of KROS is 11.58 while Keros Therapeutics 20-day EMA is 11.50, which makes it a Buy.
-
Keros Therapeutics 50-day exponential moving average is 16.19 while KROS share price is 11.58, making it a Sell technically.
-
KROS stock price is 11.58 and Keros Therapeutics 200-day simple moving average is 35.52, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.38 per share, an increase this year of $1.72 per share, and a decrease next year of $1.36 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -0.5, suggesting Keros Therapeutics is a Sell
-
Keros Therapeutics Relative Strength Index (RSI) is 46.18, which suggest Keros Therapeutics is oversold
-
The Bollinger Bands (25) for Keros Therapeutics is ( - ), which suggest Keros Therapeutics is a Buy
-
The Bollinger Bands (100) for Keros Therapeutics is ( - ), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.